The endoscopic device, called angle-resolved low coherence interferometry, is used to reach the esophagus through the nose. Physicians can then shine light in short intervals, and the sensors capture and interpret the light as it is reflected back to the physician. The method helps spot abnormal changes in cells occurring in the epithelium, where approximately 85 percent of all cancers begin.
Researchers say the technique can be used as testing for patients who may have Barrett’s esophagus and also has potential as a testing system for other types of cancer, such as colon cancer and cervical cancer.
Read the report about angle-resolved low coherence interferometry.
Read other coverage about gastrointestinal treatment:
– Researchers Spotlight “Promising” New Treatments for Irritable Bowel Syndrome
– Researchers Suggest High Endoscopy Completion Rates Tied to Fewer Missed Colorectal Cancers
– Regular Physician Activity Helps Lower Risk of Colon Cancer
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
